Lidocaine Versus Duloxetine for the Prevention of Taxane-Induced Peripheral Neuropathy In Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Peripheral Neuropathy|Chemotherapy-induced Peripheral Neuropathy|Breast Cancer
Interventions: DRUG: Lidocaine in Saline|DRUG: Duloxetine 30 MG|DRUG: Normal saline
Sponsor: Gamal Mohamed Taha Abouelmagd